Segall Bryant & Hamill, LLC Bio Rad Laboratories, Inc. Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $5,275 - $6,840	-15 Reduced 3.05%	477 $200,000
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $9,076 - $12,391	-22 Reduced 4.28%	492 $204,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $5,564 - $7,165	-12 Reduced 2.28%	514 $254,000
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $3.73 Million - $5.23 Million	-7,109 Reduced 93.11%	526 $296,000
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $1.72 Million - $1.93 Million	-2,423 Reduced 24.09%	7,635 $5.77 Million
Q3 2021 Nov 03, 2021	SELL	$657.71 - $825.77 $1.92 Million - $2.41 Million	-2,920 Reduced 22.5%	10,058 $7.5 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $77,269 - $86,971	-134 Reduced 1.02%	12,978 $8.36 Million
Q1 2021 May 13, 2021	BUY	$547.01 - $662.35 $899,831 - $1.09 Million	1,645 Added 14.35%	13,112 $7.49 Million
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $5.82 Million - $7.33 Million	-11,388 Reduced 49.83%	11,467 $6.68 Million
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $1.18 Million - $1.4 Million	2,606 Added 12.87%	22,855 $11.8 Million
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $1.46 Million - $2.15 Million	-4,369 Reduced 17.75%	20,249 $9.14 Million
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $238,087 - $304,348	744 Added 3.12%	24,618 $8.63 Million
Q4 2019 Feb 11, 2020	SELL	$319.73 - $374.2 $517,323 - $605,455	-1,618 Reduced 6.35%	23,874 $8.83 Million
Q3 2019 Nov 12, 2019	BUY	$304.55 - $345.24 $27,714 - $31,416	91 Added 0.36%	25,492 $8.48 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $156,950 - $170,986	547 Added 2.2%	25,401 $0
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $80,299 - $113,632	-358 Reduced 1.42%	24,854 $0
Q4 2018 Feb 15, 2019	BUY	$220.1 - $309.0 $126,117 - $177,057	573 Added 2.33%	25,212 $5.85 Million
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $327,464 - $369,201	-1,132 Reduced 4.39%	24,639 $0
Q2 2018 Aug 08, 2018	SELL	$244.1 - $303.88 $333,440 - $415,100	-1,366 Reduced 5.03%	25,771 $0
Q1 2018 May 16, 2018	SELL	$233.97 - $274.11 $418,104 - $489,834	-1,787 Reduced 6.18%	27,137 $0
Q4 2017 Feb 15, 2018	SELL	$216.94 - $271.3 $1.35 Million - $1.69 Million	-6,229 Reduced 17.72%	28,924 $0
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $7.46 Million - $8.52 Million	35,153	35,153 $0

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account